학술논문
900P - Phase II study of individualized sunitinib (SUN) as first-line therapy for metastatic renal cell cancer: Pharmacokinetic data
Document Type
Abstract
Author
Source
In Annals of Oncology September 2017 28 Supplement 5:v319-v319
Subject
Language
ISSN
0923-7534